Industry

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

52-week Phase 3 trial evaluating the efficacy and safety of sonlicromanol, a novel brain-penetrant redox-modulator with anti-ferroptotic and anti-inflammatory properties, in adult patients with the most common genetic defect causing primary mitochondrial disease, m.3243A>G Primary endpoints focus on most bothersome and frequently occurring effects of disease – chronic fatigue and muscle weakness – supported by … [Read more…]

Simplify Healthcare®, Sagility, and Convey Health Solutions Announce Strategic Alliance to Launch Sagility Synchrony

AURORA, Ill.–(BUSINESS WIRE)–Simplify Healthcare®, a Simplify Group™ company and a leading organization in the healthcare payer technology space, today announced a strategic alliance with Sagility and Convey Health Solutions (Convey) to launch Sagility Synchrony, a purpose-built, end-to-end Medicare Advantage lifecycle solution. Sagility Synchrony replaces fragmented point solutions with a Sagility-led, end-to-end managed services model powered … [Read more…]

Walmart Expands Access to Weight Management Support Services for Customers on or exploring GLP-1s

Better Care Services platform connects customers to virtual care and nutrition support, complementing fast, convenient access to medications through Walmart’s nationwide pharmacy network BENTONVILLE, Ark.–(BUSINESS WIRE)–As more customers seek support for weight management and overall health, Walmart is expanding its Better Care Services platform with new offerings that bring together virtual care, nutrition services and … [Read more…]

Fullscript Journeys Launches, Putting 125,000 Providers Back at the Center of the DTC Health Boom

Condition-specific lab packages starting at $50 give providers the tools to compete with self-service health subscriptions OTTAWA, Ontario–(BUSINESS WIRE)–Fullscript, a provider-led health platform doing over $1B in revenue annually, used by more than 125,000 healthcare providers and more than 5 million patients annually across North America, today announced the general availability of Fullscript Journeys, a … [Read more…]

A Joint Research Project With Université Laval Aims to Enable Aplantex to Increase Its Production of High-Value Molecules

MONTREAL–(BUSINESS WIRE)–“This research project, benefiting from a budget of $2.2 million, one of six jointly supported by Genome Canada and Génome Québec, aims to set up a high-throughput platform integrating genetic transformation, multi-omics analyses, and phenotype detection through hyperspectral imaging, using artificial intelligence, allowing for accelerated selection of clonal plant lines,” says Dr. Davoud Torkamaneh, … [Read more…]

Integrant Awarded Nasdaq Ticker “INGT” Ahead of Highly Anticipated IPO

SYDNEY–(BUSINESS WIRE)–#ArtificialIntelligence–Integrant, a pioneering Australian biotechnology company, proudly announced today that it has officially been granted the Nasdaq ticker symbol **INGT**. This milestone facilitates the company’s highly anticipated Initial Public Offering (IPO) on the Nasdaq Stock Market, positioning Integrant as a global leader in AI-enhanced regenerative medicine. Established in Sydney, Integrant specialises in the seamless … [Read more…]

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia & GRAPEVINE, Texas–(BUSINESS WIRE)–Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on April 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to … [Read more…]

Align Technology Recognized for the Fifth Consecutive Year as a LexisNexis Top 100 Global Innovator, Earning “Five-Year Top 100 Global Innovator” Distinction

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align has again been recognized, for the fifth consecutive year, as a Top 100 Global … [Read more…]

Wisconsin Supreme Court Sides with Family in Asbestos Case Against Pabst Brewing Co.

Decision reinforces workplace safety obligations for companies and contractors on-site MILWAUKEE–(BUSINESS WIRE)–The Wisconsin Supreme Court has affirmed that Pabst Brewing Co. can be held liable for asbestos exposure at its Milwaukee brewery, marking the latest development in long-running litigation brought by the family of a steamfitter who died from mesothelioma. The case was decided in … [Read more…]

SurGenTec Secures FDA 510(k) Clearance for TiLink™ SI joint fusion- Now Navigation Compatible

BOCA RATON, Fla.–(BUSINESS WIRE)–$ISRG #FDAcleared–SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its TiLink™ Navigation Instruments for use with the TiLink™ SI Joint Fusion System in sacroiliac joint procedures. The system is engineered for compatibility with Medtronic’s StealthStation™ … [Read more…]